Technical Analysis for HQL - H&Q Life Sciences Investors

Grade Last Price % Change Price Change
D 14.30 0.63% 0.09
HQL closed up 0.63 percent on Wednesday, November 20, 2024, on 1.8 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
Earnings due: Dec 9
*** please verify all earnings dates ***
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Down Down

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
NR7 Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Up 3 Days in a Row Strength 0.00%
Lower Bollinger Band Walk Weakness 0.63%
Lower Bollinger Band Touch Weakness 0.63%
Oversold Stochastic Weakness 0.63%
New Downtrend Bearish 0.92%
Jack-in-the-Box Bearish Bearish Swing Setup 0.92%

   Recent Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

H&Q Life Sciences Investors Description

H&Q Life Sciences Investors is a close ended equity mutual fund launched and managed by Hambrecht & Quist Capital Management, LLC. The fund invests in the public equity markets across the globe. It invests in stocks of companies operating in the health technology and life sciences industries. It also invests in stocks of early and later stage financings of privately held companies, private placements by public companies. The fund invests in growth stocks of companies operating across all market capitalizations. It employs fundamental analysis with a focus on factors such as potential for above-average, long-term growth in revenues and earnings securities strong market position for their services or products, experienced business management, and, recognized technological expertise. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. H&Q Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.


Classification

Sector: Financial Services
Industry: Asset Management
Keywords: Stock Fund Business Management Health Technology Nasdaq Biotech Experienced Business Management

Is HQL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 15.684
52 Week Low 10.5711
Average Volume 73,844
200-Day Moving Average 13.85
50-Day Moving Average 14.96
20-Day Moving Average 14.73
10-Day Moving Average 14.62
Average True Range 0.26
RSI (14) 40.83
ADX 27.75
+DI 17.47
-DI 40.90
Chandelier Exit (Long, 3 ATRs) 14.57
Chandelier Exit (Short, 3 ATRs) 14.49
Upper Bollinger Bands 15.50
Lower Bollinger Band 13.96
Percent B (%b) 0.22
BandWidth 10.47
MACD Line -0.19
MACD Signal Line -0.11
MACD Histogram -0.0823
Fundamentals Value
Market Cap 383.11 Million
Num Shares 26.8 Million
EPS 0.79
Price-to-Earnings (P/E) Ratio 18.10
Price-to-Sales 107.46
Price-to-Book 0.92
PEG Ratio 0.00
Dividend 1.30
Dividend Yield 9.09%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 14.48
Resistance 3 (R3) 14.48 14.43 14.45
Resistance 2 (R2) 14.43 14.38 14.42 14.44
Resistance 1 (R1) 14.36 14.35 14.39 14.36 14.43
Pivot Point 14.31 14.31 14.32 14.31 14.31
Support 1 (S1) 14.24 14.26 14.28 14.24 14.17
Support 2 (S2) 14.19 14.23 14.19 14.16
Support 3 (S3) 14.12 14.19 14.15
Support 4 (S4) 14.12